Literature DB >> 6503574

Past, present, and future applications of the auditory middle latency response.

F E Musiek, N A Geurkink, D J Weider, K Donnelly.   

Abstract

For many years (auditory) middle latency response (MLR) reportedly has been an excellent electrophysiological procedure for estimating frequency specific auditory thresholds. Currently the 40 Hz potential, a derivative of the MLR, holds even greater promise for threshold testing. MLR also appears to have potentially valuable applications in the evaluation of functional hearing loss and assessment of higher auditory function. However, MLR is not without controversy. Questions of origin, filtering effects, and its use in pediatric assessment are current issues surrounding applications of MLR. The following article analyzes the values and limitations of MLR within the framework of past, present, and future research and clinical uses.

Entities:  

Mesh:

Year:  1984        PMID: 6503574     DOI: 10.1288/00005537-198412000-00002

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Auditory middle latency responses in children with specific language impairment.

Authors:  Saud S Al-Saif; Mohamed M Abdeltawwab; Mahmoud Khamis
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-03       Impact factor: 2.503

2.  Lateralization and Binaural Interaction of Middle-Latency and Late-Brainstem Components of the Auditory Evoked Response.

Authors:  Andrew R Dykstra; Daniel Burchard; Christian Starzynski; Helmut Riedel; Andre Rupp; Alexander Gutschalk
Journal:  J Assoc Res Otolaryngol       Date:  2016-05-19

3.  A study of logon-evoked middle latency responses in female subjects with normal hearing.

Authors:  Erika Maria Fukushima; Ney Penteado de Castro
Journal:  Braz J Otorhinolaryngol       Date:  2007 May-Jun

4.  Auditory Middle Latency Responses: a study of healthy children.

Authors:  Ana Claudia Figueiredo Frizzo; Carolina Araújo Rodrigues Funayama; Myriam Lima Isaac; José Fernando Colafêmina
Journal:  Braz J Otorhinolaryngol       Date:  2007 May-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.